The objective of this randomized study is to compare the safety and efficacy of the ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent to the everolimus-eluting family stents (durable polymer everolimus-eluting Xience or Promus stents) in a population-based setting with coronary artery stenosis treated with percutaneous coronary intervention
All patients aged ≥18 years who are eligible for treatment with one or several drug-eluting coronary stents
Age < 18 years
Not able to consent to study participating (eg. intubated patients)
Unstable circuit or in cardiogenic shock and therefore not able to understand the information and purpose of the study
Do not speak Danish